nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritonavir—ABCG2—Topotecan—cervical cancer	0.503	0.634	CbGbCtD
Ritonavir—ABCB1—Topotecan—cervical cancer	0.181	0.229	CbGbCtD
Ritonavir—CYP3A4—Topotecan—cervical cancer	0.109	0.137	CbGbCtD
Ritonavir—Acute leukaemia—Topotecan—cervical cancer	0.0106	0.089	CcSEcCtD
Ritonavir—Pelvic pain—Topotecan—cervical cancer	0.00498	0.0418	CcSEcCtD
Ritonavir—Neuralgia—Topotecan—cervical cancer	0.00436	0.0366	CcSEcCtD
Ritonavir—Lung disorder—Topotecan—cervical cancer	0.00428	0.036	CcSEcCtD
Ritonavir—Interstitial lung disease—Topotecan—cervical cancer	0.00428	0.036	CcSEcCtD
Ritonavir—Blood bilirubin increased—Topotecan—cervical cancer	0.00321	0.0269	CcSEcCtD
Ritonavir—Bone pain—Topotecan—cervical cancer	0.00317	0.0266	CcSEcCtD
Ritonavir—Respiratory failure—Topotecan—cervical cancer	0.00309	0.0259	CcSEcCtD
Ritonavir—Colitis—Topotecan—cervical cancer	0.00291	0.0244	CcSEcCtD
Ritonavir—SLC47A1—uterine cervix—cervical cancer	0.00289	0.0328	CbGeAlD
Ritonavir—Neuropathy—Topotecan—cervical cancer	0.00285	0.0239	CcSEcCtD
Ritonavir—Rash maculo-papular—Topotecan—cervical cancer	0.00276	0.0231	CcSEcCtD
Ritonavir—SLC47A1—decidua—cervical cancer	0.00275	0.0313	CbGeAlD
Ritonavir—SLC47A1—renal system—cervical cancer	0.0027	0.0307	CbGeAlD
Ritonavir—SLCO1B1—renal system—cervical cancer	0.00267	0.0303	CbGeAlD
Ritonavir—SLC47A1—endometrium—cervical cancer	0.00261	0.0297	CbGeAlD
Ritonavir—Ear pain—Topotecan—cervical cancer	0.00258	0.0217	CcSEcCtD
Ritonavir—SLC47A1—mammalian vulva—cervical cancer	0.00253	0.0287	CbGeAlD
Ritonavir—SLC47A1—uterus—cervical cancer	0.00241	0.0273	CbGeAlD
Ritonavir—Dermatitis bullous—Topotecan—cervical cancer	0.0023	0.0193	CcSEcCtD
Ritonavir—SLCO1A2—renal system—cervical cancer	0.00217	0.0247	CbGeAlD
Ritonavir—SLC47A1—female reproductive system—cervical cancer	0.00216	0.0246	CbGeAlD
Ritonavir—SLCO1B1—female reproductive system—cervical cancer	0.00214	0.0243	CbGeAlD
Ritonavir—ABCC2—renal system—cervical cancer	0.00202	0.023	CbGeAlD
Ritonavir—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00198	0.0166	CcSEcCtD
Ritonavir—Cramp muscle—Topotecan—cervical cancer	0.00198	0.0166	CcSEcCtD
Ritonavir—SLC47A1—female gonad—cervical cancer	0.00197	0.0224	CbGeAlD
Ritonavir—SLC47A1—vagina—cervical cancer	0.00196	0.0222	CbGeAlD
Ritonavir—ABCC1—uterine cervix—cervical cancer	0.0019	0.0216	CbGeAlD
Ritonavir—ABCC1—decidua—cervical cancer	0.00181	0.0206	CbGeAlD
Ritonavir—Neutropenia—Topotecan—cervical cancer	0.00178	0.0149	CcSEcCtD
Ritonavir—ABCC1—endometrium—cervical cancer	0.00172	0.0196	CbGeAlD
Ritonavir—ABCC1—mammalian vulva—cervical cancer	0.00167	0.0189	CbGeAlD
Ritonavir—Neuropathy peripheral—Topotecan—cervical cancer	0.00166	0.014	CcSEcCtD
Ritonavir—Stomatitis—Topotecan—cervical cancer	0.00165	0.0139	CcSEcCtD
Ritonavir—Sweating—Topotecan—cervical cancer	0.00163	0.0136	CcSEcCtD
Ritonavir—ABCC2—female reproductive system—cervical cancer	0.00162	0.0184	CbGeAlD
Ritonavir—Hepatobiliary disease—Topotecan—cervical cancer	0.0016	0.0135	CcSEcCtD
Ritonavir—Epistaxis—Topotecan—cervical cancer	0.0016	0.0134	CcSEcCtD
Ritonavir—ABCC1—uterus—cervical cancer	0.00159	0.018	CbGeAlD
Ritonavir—ABCG2—uterine cervix—cervical cancer	0.00158	0.0179	CbGeAlD
Ritonavir—Haemoglobin—Topotecan—cervical cancer	0.00153	0.0128	CcSEcCtD
Ritonavir—Rhinitis—Topotecan—cervical cancer	0.00153	0.0128	CcSEcCtD
Ritonavir—Haemorrhage—Topotecan—cervical cancer	0.00152	0.0128	CcSEcCtD
Ritonavir—CYP2C8—renal system—cervical cancer	0.00152	0.0172	CbGeAlD
Ritonavir—Hypoaesthesia—Topotecan—cervical cancer	0.00152	0.0127	CcSEcCtD
Ritonavir—Pharyngitis—Topotecan—cervical cancer	0.00151	0.0127	CcSEcCtD
Ritonavir—ABCG2—decidua—cervical cancer	0.0015	0.0171	CbGeAlD
Ritonavir—CYP2C8—endometrium—cervical cancer	0.00147	0.0167	CbGeAlD
Ritonavir—CYP3A5—uterine cervix—cervical cancer	0.00146	0.0166	CbGeAlD
Ritonavir—ABCG2—endometrium—cervical cancer	0.00143	0.0162	CbGeAlD
Ritonavir—CYP1A2—renal system—cervical cancer	0.00142	0.0161	CbGeAlD
Ritonavir—Angiopathy—Topotecan—cervical cancer	0.00138	0.0116	CcSEcCtD
Ritonavir—ABCG2—mammalian vulva—cervical cancer	0.00138	0.0157	CbGeAlD
Ritonavir—Immune system disorder—Topotecan—cervical cancer	0.00138	0.0115	CcSEcCtD
Ritonavir—Mediastinal disorder—Topotecan—cervical cancer	0.00137	0.0115	CcSEcCtD
Ritonavir—CYP3A5—renal system—cervical cancer	0.00137	0.0156	CbGeAlD
Ritonavir—Chills—Topotecan—cervical cancer	0.00137	0.0115	CcSEcCtD
Ritonavir—CYP2B6—renal system—cervical cancer	0.00136	0.0155	CbGeAlD
Ritonavir—Malnutrition—Topotecan—cervical cancer	0.00133	0.0111	CcSEcCtD
Ritonavir—ABCG2—uterus—cervical cancer	0.00131	0.0149	CbGeAlD
Ritonavir—ABCC1—female gonad—cervical cancer	0.0013	0.0147	CbGeAlD
Ritonavir—ABCC1—vagina—cervical cancer	0.00129	0.0147	CbGeAlD
Ritonavir—Back pain—Topotecan—cervical cancer	0.00128	0.0108	CcSEcCtD
Ritonavir—CYP2E1—renal system—cervical cancer	0.00128	0.0145	CbGeAlD
Ritonavir—Muscle spasms—Topotecan—cervical cancer	0.00127	0.0107	CcSEcCtD
Ritonavir—SLC47A1—lymph node—cervical cancer	0.00127	0.0144	CbGeAlD
Ritonavir—CYP2C19—vagina—cervical cancer	0.00126	0.0143	CbGeAlD
Ritonavir—Ill-defined disorder—Topotecan—cervical cancer	0.00123	0.0103	CcSEcCtD
Ritonavir—Anaemia—Topotecan—cervical cancer	0.00123	0.0103	CcSEcCtD
Ritonavir—CYP2C8—female reproductive system—cervical cancer	0.00122	0.0138	CbGeAlD
Ritonavir—Malaise—Topotecan—cervical cancer	0.0012	0.01	CcSEcCtD
Ritonavir—Leukopenia—Topotecan—cervical cancer	0.00119	0.00996	CcSEcCtD
Ritonavir—Cough—Topotecan—cervical cancer	0.00116	0.00971	CcSEcCtD
Ritonavir—Myalgia—Topotecan—cervical cancer	0.00113	0.00947	CcSEcCtD
Ritonavir—Chest pain—Topotecan—cervical cancer	0.00113	0.00947	CcSEcCtD
Ritonavir—Arthralgia—Topotecan—cervical cancer	0.00113	0.00947	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00112	0.00941	CcSEcCtD
Ritonavir—Discomfort—Topotecan—cervical cancer	0.00112	0.00936	CcSEcCtD
Ritonavir—CYP2C8—vagina—cervical cancer	0.0011	0.0125	CbGeAlD
Ritonavir—CYP2B6—female reproductive system—cervical cancer	0.00109	0.0124	CbGeAlD
Ritonavir—CYP2C9—female reproductive system—cervical cancer	0.00108	0.0123	CbGeAlD
Ritonavir—ABCG2—female gonad—cervical cancer	0.00108	0.0122	CbGeAlD
Ritonavir—ABCG2—vagina—cervical cancer	0.00107	0.0121	CbGeAlD
Ritonavir—Nervous system disorder—Topotecan—cervical cancer	0.00106	0.0089	CcSEcCtD
Ritonavir—Thrombocytopenia—Topotecan—cervical cancer	0.00106	0.00889	CcSEcCtD
Ritonavir—Skin disorder—Topotecan—cervical cancer	0.00105	0.00882	CcSEcCtD
Ritonavir—Hyperhidrosis—Topotecan—cervical cancer	0.00105	0.00878	CcSEcCtD
Ritonavir—Anorexia—Topotecan—cervical cancer	0.00103	0.00865	CcSEcCtD
Ritonavir—CYP3A4—renal system—cervical cancer	0.00103	0.0117	CbGeAlD
Ritonavir—CYP2E1—female reproductive system—cervical cancer	0.00102	0.0116	CbGeAlD
Ritonavir—CYP2D6—renal system—cervical cancer	0.00101	0.0115	CbGeAlD
Ritonavir—CYP3A5—female gonad—cervical cancer	0.000998	0.0113	CbGeAlD
Ritonavir—CYP3A5—vagina—cervical cancer	0.000992	0.0113	CbGeAlD
Ritonavir—CYP2B6—vagina—cervical cancer	0.000986	0.0112	CbGeAlD
Ritonavir—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000986	0.00827	CcSEcCtD
Ritonavir—Paraesthesia—Topotecan—cervical cancer	0.000972	0.00815	CcSEcCtD
Ritonavir—Dyspnoea—Topotecan—cervical cancer	0.000965	0.00809	CcSEcCtD
Ritonavir—Dyspepsia—Topotecan—cervical cancer	0.000952	0.00799	CcSEcCtD
Ritonavir—ABCC2—lymph node—cervical cancer	0.000948	0.0108	CbGeAlD
Ritonavir—Decreased appetite—Topotecan—cervical cancer	0.000941	0.00789	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Topotecan—cervical cancer	0.000934	0.00784	CcSEcCtD
Ritonavir—Fatigue—Topotecan—cervical cancer	0.000933	0.00783	CcSEcCtD
Ritonavir—Constipation—Topotecan—cervical cancer	0.000925	0.00776	CcSEcCtD
Ritonavir—Pain—Topotecan—cervical cancer	0.000925	0.00776	CcSEcCtD
Ritonavir—Feeling abnormal—Topotecan—cervical cancer	0.000892	0.00748	CcSEcCtD
Ritonavir—Gastrointestinal pain—Topotecan—cervical cancer	0.000885	0.00742	CcSEcCtD
Ritonavir—Urticaria—Topotecan—cervical cancer	0.00086	0.00721	CcSEcCtD
Ritonavir—Abdominal pain—Topotecan—cervical cancer	0.000855	0.00718	CcSEcCtD
Ritonavir—Body temperature increased—Topotecan—cervical cancer	0.000855	0.00718	CcSEcCtD
Ritonavir—ABCC1—lymph node—cervical cancer	0.000835	0.00948	CbGeAlD
Ritonavir—CYP3A4—female reproductive system—cervical cancer	0.000823	0.00935	CbGeAlD
Ritonavir—CYP2D6—female reproductive system—cervical cancer	0.00081	0.0092	CbGeAlD
Ritonavir—Hypersensitivity—Topotecan—cervical cancer	0.000797	0.00669	CcSEcCtD
Ritonavir—ABCB1—epithelium—cervical cancer	0.000784	0.00891	CbGeAlD
Ritonavir—ABCB1—uterine cervix—cervical cancer	0.000778	0.00883	CbGeAlD
Ritonavir—Asthenia—Topotecan—cervical cancer	0.000776	0.00651	CcSEcCtD
Ritonavir—Pruritus—Topotecan—cervical cancer	0.000765	0.00642	CcSEcCtD
Ritonavir—ABCB1—decidua—cervical cancer	0.000741	0.00841	CbGeAlD
Ritonavir—Diarrhoea—Topotecan—cervical cancer	0.00074	0.00621	CcSEcCtD
Ritonavir—CYP2D6—female gonad—cervical cancer	0.000737	0.00837	CbGeAlD
Ritonavir—ABCB1—renal system—cervical cancer	0.000727	0.00826	CbGeAlD
Ritonavir—Dizziness—Topotecan—cervical cancer	0.000715	0.006	CcSEcCtD
Ritonavir—ABCB1—endometrium—cervical cancer	0.000703	0.00799	CbGeAlD
Ritonavir—ABCG2—lymph node—cervical cancer	0.000691	0.00785	CbGeAlD
Ritonavir—Vomiting—Topotecan—cervical cancer	0.000688	0.00577	CcSEcCtD
Ritonavir—Rash—Topotecan—cervical cancer	0.000682	0.00572	CcSEcCtD
Ritonavir—Dermatitis—Topotecan—cervical cancer	0.000682	0.00572	CcSEcCtD
Ritonavir—ABCB1—mammalian vulva—cervical cancer	0.00068	0.00773	CbGeAlD
Ritonavir—Headache—Topotecan—cervical cancer	0.000678	0.00569	CcSEcCtD
Ritonavir—ABCB1—uterus—cervical cancer	0.000648	0.00736	CbGeAlD
Ritonavir—Nausea—Topotecan—cervical cancer	0.000643	0.00539	CcSEcCtD
Ritonavir—ABCB1—female reproductive system—cervical cancer	0.000583	0.00662	CbGeAlD
Ritonavir—ABCB1—female gonad—cervical cancer	0.00053	0.00602	CbGeAlD
Ritonavir—ABCB1—vagina—cervical cancer	0.000527	0.00598	CbGeAlD
Ritonavir—ABCB1—lymph node—cervical cancer	0.000341	0.00387	CbGeAlD
